Member Info for wintzy

After hours RNSs. All seems good. What do the experts think?

Bladey...have you a link to Myles comment? Is it on Twitter?

Now being posted.

This has sparked before prior to a mention on the DB. Maybe thats the case this evening.

You must be right, as its a sea of blue "officially".

Re those that have had the disease. If you have antibodies, thats good for the individual, although immunity is not yet proved. More crucially, as Scottish Government doctor said tonight, they don't know whether you can catch it again, have no symptoms, but can still infect other people.

I mean "annoyance" to ours getting adopted by the Government. Not in the progress of beating this virus.

Its a British invention. A hand held reader is required. It takes 75 minutes. Doesn't mention cost of the reader.
AVCT test sounds streets ahead, but this is a bit of an annoyance.

Another Antigen test approved:
"The government has been piloting the DnaNudge test since April with 10,000 kits used in London hospitals. After approval this month from the Medicines and Healthcare products Regulatory Agency (MHRA) for widespread clinical use, a further 70,000 testing kits were delivered to hospitals.
Unlike the standard Covid-19 test that requires invasive swabbing of the throat and nose, the DnaNudge detects the virus from a small swab of the nostril. This is inserted into a handheld reader that provides results within 75 minutes, eliminating the need to send samples to laboratories to be processed, which can take up to 72 hours.
The development team at Imperial College London (ICL) says the test is the first of its kind to have the MHRA’s approval for mass use in hospitals.
The next step is to make it available for people to buy at £40 for home use and for companies to get staff back into offices. They aim to carry out 300,000 tests a month by September and one million a month by the end of the year.#

The Daily Mail are running a story on yet another antigen test. I am not sure I can post the link. Here is a brief extract:
"Biotech company Oxford Nanopore is working on a portable swab-recording device called LamPORE, which can determine whether a user has coronavirus in the space of an hour. "

Hurley I did correct you! Anyway, I think most holders will be on board with the news. In the UK at about 5.00pm there is a Daily Briefing on CV. Tonight the Roche antibody test was discussed (not new news) AND an antigen test which will be trialled in Hampshire, UK (this was new news). This antigen test has been developed by a company called Optigene. The test is different to ours. But its an antigen test nevertheless.

Hurley..you are wrong.

At_home....the Optigene test is an antigen test. The antibody tests are coming from Roche,

Maybe there is an announcement about to break in the US.

Good to get press coverage, but any laymen would see the headline and think Boohoo are developing this test! You have to read down to find that actually its a company called Avacta doing the science and Boohoo will be in distribution mode only. Poor journalism.

Well lots of views. What I'm taking from the RNS is that there is 100% confidence in this antigen POC test getting approved. That it works is no longer in doubt IMO. That is the key message here. I hope we get Miles' considered views during the day....or has he already commented?

You most definitely don't live in Australia! NZ maybe.

I suppose the additional funding and Astra Zeneca agreement re Oxford Uni is good news for OXB? Announced in this evenings Daily Briefing. Sounds like good news for the UK and wider world! Just needs to be a successful vaccine!

Interesting:
https://www.forbes.com/sites/katiejennings/2020/05/07/fda-authorizes-first-ever-crispr-application-for-covid-19-coronavirus-test/#37c878dd1708
And the penultimates para States:
"Sherlock is currently working with an undisclosed partner on scaling up access to its diagnostic tests at high volume, and Dhanda expects to make an announcement on that rollout in the coming weeks. The company is also working on another test called INSPECTR, which people would be able to use in their homes, rather than in a lab setting. That synthetic biology-based product would be able to provide users a positive or negative result on a strip of paper."

They are mentioned under the Avacta Group heading.